Table 1.
Sociodemographic and clinical characteristics of respondents 2016/2017 (n = 239).
Table 2.
IPs based on individual STOPS/START criteria among older CVPs in 2016/2017 (n = 221).
Fig 1.
The top ten common drugs associated with IP among CVPs admitted to UOGH, 2016/2017.
Table 3.
IPs in elderly CVPs presented with different diagnosis at UOGH 2016/17: One way ANOVA test.
Table 4.
Factors affecting IPs in elderly CVPS attending UOGH 2016/2017.